PET imaging in pediatric oncology by Shulkin, Barry L.
Introduction
Over the past 20 years, there has been considerable
progress in PET technology, which has made pediatric
PET imaging feasible and much more pediatric friendly
[1]. The technology has evolved from time-consuming
and effort-intense to virtually routine. Early on, the
primary application of PET was brain imaging and the
first units were head-only devices.
Whole-body devices became commercially available
in the mid to late 1980s and had a 10-cm z-axis field of
view and fixed ring sources. Transmission images for
attenuation correction had to be acquired prior to
injection of tracer. Furthermore, they were minimally
useful for positioning in that only very limited anatomic
information such as the diaphragmatic interface could
be obtained from the transmission images. Patients were
positioned before injection of tracer by correlating
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Abstract High-quality PET imaging
of pediatric patients is challenging
and requires attention to issues
commonly encountered in the prac-
tice of pediatric nuclear medicine,
but uncommon to the imaging of
adult patients. These include intra-
venous access, fasting, sedation,
consent, and clearance of activity
from the urinary tract. This paper
discusses some technical differences
involved in pediatric PET to en-
hance the quality of scans and assure
the safety and comfort of pediatric
patients.
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physical findings with CT findings. For all practical
purposes, positioning involved finding the air-soft tissue
interface at the diaphragm, then estimating how far
above or below the diaphragm to center the field of view.
Part or all of the tumor might lie outside the field of view
of the PET camera and this could not be appreciated
until after the study had been completed and then
reconstructed.
A transmission-emission scan of two bed positions
(20 cm) with this device was time consuming, requiring
about 90 min: 20 min for the transmission scan, 50 min
post-injection for adequate uptake of FDG to occur,
and 20 min for emission scans (two levels at 10 cm each,
10 min per bed position). This could be unrealistic for an
ill, hungry, uncomfortable child. Patient, parent, and
technologist tolerance for the long imaging times were
not favorable. Although images could be obtained at
multiple bed positions without attenuation correction,
the quality of non-attenuation-corrected emission scans
was variable, and whole-body imaging software was not
widely available.
There have been considerable advances in both
machinery and software. This has resulted in both
impressive reductions in acquisition times as well as
improvements in image quality. Currently, PET ma-
chines commonly feature a 15-cm z-axis field of view and
rotating rod sources. Transmission images can be ob-
tained following injection of tracer, and the larger field
of view reduces the number of bed positions needed for
imaging 60 cm from 6 to 4. ‘‘Whole-body’’ imaging has
become practical. Presently, a two-level emission-trans-
mission scan can be acquired in about 20 minutes (7-min
emission, 3-min transmission per bed position). As a
result, pediatric PET imaging is much better tolerated by
patients and technologists than in the past.
Although modern PET cameras are more pediatric
friendly than their predecessors, additional efforts are
required to make the study as tolerable as possible for
the patient and to ensure that the quality of the imaging
data is high. Preparation of the adult patient for PET
imaging has been well described [2]. A set of protocols
encompassing issues unique to pediatrics is necessary.
The following discussion is a guide to performing PET
in pediatric patients, emphasizing patient consent, IV
access, bladder catheterization, and sedation.
Consent
Initially, pediatric PET studies at our institution were
performed under research grants awarded by the
National Institutes of Health and the University of
Michigan Clinical Research Center. 18F-FDG was
administered as an investigational agent under an FDA
IND (Investigational New Drug). Institutional Review
Board (IRB) approved consent forms were required.
Although routinely complicated, IRB regulations are
even more complex when children are the patients in-
volved in research studies since they are a ‘‘vulnerable
population.’’ In contrast to studies in adult patients,
where the procedure is explained directly to the patient
and the documentation read and signed by the patient,
the pediatric patient cannot give informed consent.
Parents/guardians must grant informed consent, and it
can be difficult to locate a working parent. In our
institution, verbal consent can be obtained by telephone
by reading the entire document to the parent/guardian
with a hospital representative listening as a witness.
Because FDG PET scanning is now performed mostly
for clinical rather than research indications, the imaging
consent form is no longer regulated by the IRB. We
recommend having the patient’s treating physician
involved with the parents in introducing the need for the
PET scan. It is the parents/guardians who read the
consent documentation and require clarification and
explanation in lay terms. Since the parents may or may
not be available at the actual time of the PET scan, we
usually obtain consent the day prior to the procedure for
research studies. The technologist along with the parents
can then explain the procedure to the child in terms
more appropriate to the child’s age and medical expe-
riences.
IV access
Reliable intravenous access is critical to the study. PET
technologists are usually different personnel from pedi-
atric nuclear medicine technologists and have less
experience establishing intravenous access in children.
Establishing IV access in children, especially those
whose veins are not easily seen, can be particularly
problematic. Patients and parents do not tolerate mul-
tiple attempts at IV access. Rarely, we have had to
cancel a PET scan when IV access could not be rapidly
established in the PET suite. We frequently utilize the
skills of our colleagues in pediatric nuclear medicine,
pediatric oncology, and pediatric anesthesiology to se-
cure IV access, especially in younger children. Hospi-
talized patients will usually have an indwelling
intravenous line that can be tested and used for tracer
administration, if acceptable.
Intravenous access is best established well before the
patient is transported to the PET suite. In children
requiring anesthesia and whose imaging will begin
shortly after injection, access can be established shortly
after the induction of anesthesia as veins dilate, and pain
is no longer an issue. The child is spared the pain of
venipuncture, and the parents and technologists are
spared the accompanying screaming and anxiety. This
approach is best for patients receiving tracers for which
imaging is begun soon after injection (for example,
200
11C-hydroxyephedrine) [3]. For patients receiving 18F-
FDG, this would add at least 45 min to the anesthesia
time, as the child remains sedated while the uptake of
18F-FDG occurs, and is impractical.
A central line is present in most patients who are
going to be treated with systemic chemotherapy. This
line can be used for injection of the PET radiotracer.
The technologist should ask the parent or guardian
about the line and which port is preferred. Parents are
usually quite familiar with the function of these lines.
The line should be flushed well to clear residual tracer
from the line. The tubing should be manipulated so
that as much of it as possible lies either outside the
imaging area or to the side of the patient rather than
on top (Fig. 1). With care to flush the line, we usually
encounter very little residual activity in the line and this
residual activity does not interfere with image inter-
pretation.
Bladder catheterization
There are several reasons why bladder catheterization
may be needed. First, activity in a full bladder may
obscure or cause reconstruction artifacts interfering with
the recognition of activity in nearby structures (Fig. 2).
This aspect is particularly pertinent in small children in
whom small sites of pathologic avidity may be obscured
by avidity in adjacent normal structures such as a dis-
tended bladder. This is most important when thorough
evaluation of the pelvis is necessary or desirable. Second,
an urge to void during the study can result in patient
movement or result in voiding onto the child’s clothes or
sheets, causing embarrassment and discomfort and ad-
versely affecting image quality. Third, the preparation of
pediatric patients for anesthesia and the anesthesia itself
predispose the patient to retain activity within the uri-
nary tract. Patients must remain npo for several hours
prior to induction of anesthesia. This fluid restriction
results in intravascular volume contraction and pro-
duction of lower volume but concentrated urine (Fig. 3).
Additionally, anesthesia causes muscle relaxation,
including the smooth muscle of the bladder. This can
lead to bladder distention. For these reasons, we often
perform bladder catheterization for children undergoing
PET studies under anesthesia. Like the issues regarding
venous catheterization, insertion of a bladder catheter is
best performed by personnel experienced in the insertion
of urinary bladder catheters. We usually insert the
catheter after the patient has been anesthetized in order
to minimize patient trauma and to facilitate the proce-
dure. On one occasion, a difficult catheterization
prompted a request for assistance from our pediatric
urology service.
Once catheterized, care must be given to maintain
proper positioning of the catheter and collection device.
The collection device must be placed below the patient
for gravity drainage and away from the patient to avoid
Fig. 1A, B Eight-year-old boy with neuroblastoma at presentation.
A Anterior projection image of FDG PET scan. Activity overlying
the right kidney (arrow) is shown to represent residual radiotracer
in the injection tubing (arrow) on lateral projection image (B). The
large area of uptake is the left upper quadrant at the same level as
the right kidney, represents the primary tumor. The region of
decreased uptake within the mass is due to central necrosis
Fig. 2 Anterior projection image of FDG PET scan of 3-year-old
girl with primitive neuroectodermal tumor of the sacrum. Bladder
activity precludes adequate evaluation of the pelvis. The study was
repeated with bladder catheterization and intravenous fluids
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interference from the radioactive urine. Although this
seems obvious, nonimaging personnel can be unfamiliar
with the amount of FDG excreted through the urinary
tract and its consequences on image reconstruction and
interpretation. A small amount of urinary FDG can
contaminate a large region (Fig. 4). In our experience,
gravity drainage is adequate for maintaining bladder
decompression. We have not found a need for continu-
ous bladder irrigation.
Sedation/anesthesia
Children may need anesthesia for a PET scan just as
for other lengthy procedures in pediatric radiology:
patients who are mentally impaired, young children
who cannot cooperate/tolerate, and those who are
claustrophobic will probably need sedation. In short,
any patient with characteristics that may interrupt or
disrupt the PET scan should be considered for sedation
or anesthesia.
The preferred approach to sedation varies among
institutions and departments. Sedation/anesthesia is
delivered in accordance with institutional guidelines and
those published by the American Academy of Pediatrics
and American Society of Anesthesiology [4, 5]. Sedation
may be suitable for some patients, although we rarely
encounter patients for whom ‘‘light’’ sedation is ade-
quate. In those cases, placement of intravenous access
and bladder catheters should be performed prior to
sedation, as the arousal stimulus from those activities
may be sufficient to disrupt or terminate the sedation. In
our experience, once the child is aroused and irritated,
additional sedation is not likely to be effective. Qualified
personnel, whose sole responsibility during the scan will
be to monitor consciousness and cardiorespiratory
function continuously, must be present throughout the
entire procedure.
PET-CT devices are now commercially available.
These PET machines are quite valuable for pediatric
PET imaging and have some advantages over even state-
of-the-art stand-alone PET scanners [6]. Imaging time is
reduced for at least two reasons: (1) the quick, spiral CT
takes less than a minute and obviates the need for
transmission scans (typically 3 min per bed position); (2)
the 3D mode of acquisition of emission data has allowed
us to reduce the emission imaging time to 5 min per bed
position. The actual camera time for a four-level, 60-cm
‘‘whole-body’’ scan is less than 30 min. Additional
considerations depend upon the principal purpose of the
CT scan. As our institution has multiple state-of-the-art
dedicated CT scanners and only one clinical PET scan-
ner, the primary use of the CT scan is for attenuation
correction and secondarily for anatomic localization.
CT scans performed for attenuation correction are ob-
tained with reduced mA. This reduction decreases the
Fig. 4 Anterior projection image of 2-year-old girl with neuro-
blastoma (arrow). During catheterization, the technologist noted a
few drops of urine fall onto the underlying blue absorbent pad
(short arrows)
Fig. 3 Anterior projection image of 16-year-old boy with history of
Wilms’ tumor, status post right nephrectomy. There is considerable
radioactivity in the left kidney and urinary collecting system owing
to prolonged clearance of tracer
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absorbed dose to the patient without loss of image
quality in the reconstructed PET images. We try to limit
the ‘‘diagnostic’’ complexity of the CT scan to facilitate
tolerance of the procedure on the part of the patients
and to facilitate patient access for the medical commu-
nity. Thoracic PET CT scans are done with free
breathing in contrast to diagnostic chest CT examina-
tions often being performed with the breath-hold tech-
nique. Breath-holding with PET-CT can contribute to
misregistration between CT and PET data. In intubated
patients, this may result in atelectasis, which impairs the
quality of the CT scan, but has minimal if any effect on
the PET component (Fig. 5). Oral contrast may be given
to identify the bowel better, and that assists interpreta-
tion of the PET scan by helping to distinguish benign
uptake in the gastrointestinal tract from abnormal up-
take in adjacent soft tissues. The choice of oral contrast
agents is probably not important, and oral contrast has
been shown not to interfere substantially with image
interpretation [7]. Intravenous contrast may be useful to
outline the major vessels. However, this considerably
complicates the acquisition, as different contrast proto-
cols may be in order for the CT scans of the neck versus
chest versus abdomen. We do not routinely administer
IV contrast but can when requested by the referring
physician and when we believe that will aid the inter-
pretation of the PET scan. Although complicated CT
protocols can be accomplished on the PET CT machine,
patients may be better served by having complex CT
scans performed on dedicated CT scanners with full-
time CT personnel.
Indications for PET scanning in children
As of this writing, PET scanning in children is not
supported by the Center for Medicare and Medicaid
Services except as their conditions coincide with reim-
bursed conditions in adults. Efforts are underway to
secure financial support for PET scanning in children
with malignant diseases. We have found PET scanning
useful for the following indications: (1) the distinction of
benign from malignant neoplasms; (2) selection of the
site for biopsy; (3) staging of the malignancy; (4) deter-
mination of the response to therapy; and (5) distin-
guishing scar from residual neoplasm in children who
have completed therapy. The tumors we most commonly
Fig. 5A, B PET-CT scan of
3-year-old boy with recurrent
neuroblastoma. A Chest CT
shows bibasilar atelectasis.
B Corresponding PET image
shows no abnormal FDG
accumulation in areas of
atelectatic lungs
Fig. 6 Anterior projection image of FDG PET scan of a 17-year-
old boy with newly diagnosed nodular sclerosing Hodgkin’s
disease. Multiple abnormal mediastinal and hilar nodes are evident
(arrows)
Fig. 7 Transverse image of FDG PET scan of 12-year-old girl with
metastatic rhabdomyosarcoma shows intense activity in a metasta-
sis at the liver hilum (arrows). Bilateral renal activity is seen inferior
to the mass (dashed arrows)
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encounter are neuroblastomas, lymphomas, and soft
tissue sarcomas (Figs. 1, 6, 7) [8, 9, 10]. PET scanning
can be quite useful in the evaluation of uncommon tu-
mors, such as the peripheral nerve sheath tumor, and
hepatoblastomas, which have not yet been well charac-
terized with regard to FDG uptake and retention.
In conclusion, the use of PET to study pediatric
conditions is becoming more common. The PET tech-
nique has considerable promise for expanding our
knowledge about the pathophysiology of pediatric dis-
ease, especially oncologic disease. Tracers besides
18F-FDG, may be useful in selected clinical situations.
CMS coverage for pediatric oncology may be soon
considered. We anticipate that the application of PET in
pediatrics will continue to expand.
With particular attention to detail, high-quality
functional images that provide valuable clinical
information for the management of pediatric patients
with malignancies can be obtained using PET.
Specific issues for pediatric patients should be antici-
pated and addressed in order to maximize the
utility of the technique in this challenging group of
patients.
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